Abstract
Numerous epidemiologic studies have established a strong inverse relationship between plasma HDL levels and coronary heart disease (CHD) (Miller, 1987). Recent studies suggest that factors influencing levels and metabolism of HDL include both the composition and size of HDL and the fractional catabolic rates of apoAl or apoAll (Brinton et al., 1991). Factors modulating HDL composition and size include lipid transfer proteins (cholesteryl ester transfer protein {CETP} and phospholipid transfer protein {PLTP}) as well as enzymes, such as lecithin:cholesterol acyltransferase {LCAT} and lipases, hepatic triglyceride lipase {HTGL} and lipoprotein lipase {LPL}. Like mature HDL in human plasma, HDL precursors (designated as nascent HDL or nHDL) are also potentially subject to the above modulating agents. However, except for LCAT little is known what effect these factors may have on the structural and metabolic properties of the precursor particles or how such remodeling may influence the channeling of precursors towards specific HDL subpopulations in human plasma. LCAT-mediated transformation of apoAl-containing discoidal analogs of precursor nHDL to HDL-like products is characterized by a strong positive correlation between the size of the precursor particles and the size of their core-containing transformation products (Figure 1) (Nichols, 1990). Thus, modulation-induced change in size of nHDL particles by transfer proteins or enzymes would be expected to correspondingly shift the size of their LCAT-transformation products. In view of the association between HDL level and HDL particle size and composition, reduction in nHDL size may contribute to lower HDL levels and increased risk of CHD. Since nHDL lack core lipids and consist almost exclusively of phospholipid, unesterified cholesterol and apolipoproteins, their remodeling mainly involves phospholipid depletion as facilitated by CETP and PLTP and phospholipid lipolysis as facilitated by HTGL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson DW, Nichols AV, Forte TM, Lindgren FT (1977) Particle distribution of human serum high density lipoproteins. Biochim Biophys Acta; 493: 55–68
Brinton EA, Eisenberg S, Breslow JL (1991) Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest; 87: 536–544
Jonas A, Kezdy KE, Wald JH (1989) Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J Biol Chem; 264: 4818–4824
Matz CE, Jonas A (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem; 257: 4535–4540
Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J; 113: 589–597
Nichols AV, Blanche PJ, Gong EL (1983) Gradient gel electrophoresis of human plasma high density lipoproteins. In: Lewis L, Opplt J, eds. CRC Handbook of Electrophoresis Vol III. Boca Raton: CRC Press; 2947
Nichols AV, Gong EL, Blanche PJ, Forte TM, Shore VG (1987) Origin and heterogeneity of HDL subspecies. In: Lippel K, ed. Proceedings of the Workshop on Lipoprotein Heterogeneity. NIH Publication No. 87–2646; 331–340
Nichols AV, Gong EL, Blanche PJ, Forte TM (1989) HDL populations: Origins and interconversions. In: Miller NE, ed. Proceedings of the 2nd International Workshop on HDL and Atherosclerosis. Amsterdam: Elsevier; 159–171
Nichols AV, Gong EL, Blanche PJ, Forte TM, Shore VG (1987) Pathways in the formation of human plasma high density lipoprotein subpopulations containing apolipoproteins AI without apolipoprotein AII. J Lipid Res 28: 719–732
Nichols AV, Gong EL, Blanche, Forte TM (1983) Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis. Biochim Biophys Acta 750: 353–364
Nichols AV (1990) Conversions in the origins and metabolism of human plasma HDL. In: Esfahani M, Swaney J, eds. Advances in Cholesterol Research. Caldwell: Telford Press; 315–365
Ohnishi T, Yokoyama S, Yamaxioto A (1990) Rapid purification of human plasma transfer proteins. J Lipid Res 31: 397–406
Swaney JB (1980) Properties of lipid-apolipoprotein association products. J Biol Chem 255: 877–881
Tall A, Swenson T, Hesler C, Granot E (1987) Mechansims of facilitated lipid transfer mediated by plasma lipid transfer proteins. In: Gotto AM Jr., ed. Plasma Lipoproteins. Amsterdam: Elsevier; 277–297
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gong, E.L., Nichols, A.V., Tall, A.R. (1993). Lipid Transport by Apolipoprotein AI: Structure and Function. In: Sirtori, C.R., Franceschini, G., Brewer, B.H. (eds) Human Apolipoprotein Mutants III. NATO ASI Series, vol 73. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84634-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-84634-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84636-6
Online ISBN: 978-3-642-84634-2
eBook Packages: Springer Book Archive